Clinical Trials Browser

Phase 3 × Imlunestrant × 1 year × Clear all

NCT05514054 2026-01-29

EMBER-4

Phase 3 Active not recruiting

Breast Neoplasms

NCT04975308 2025-07-11

EMBER-3

Phase 3 Active not recruiting

874 enrolled 29 charts 1 FDA

Breast Neoplasms, Neoplasm Metastasis